Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Observation of Treatment Patterns With Lucentis® (Ranibizumab) in Real-life Conditions in All Approved Indications

Authors not listed

Novartis Pharmaceuticals · 2015

Abstract

This study is designed as an observational, non-interventional, multicenter, open label, single arm study in patients being treated with Lucentis® for any approved indication included in the local product posology.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-26 MST

Cite this

APA
Anonymous. (2015). Observation of Treatment Patterns With Lucentis® (Ranibizumab) in Real-life Conditions in All Approved Indications. <em>Novartis Pharmaceuticals</em>. https://clinicaltrials.gov/study/NCT04847895
Vancouver
Anonymous. Observation of Treatment Patterns With Lucentis® (Ranibizumab) in Real-life Conditions in All Approved Indications. Novartis Pharmaceuticals. 2015.
BibTeX
@misc{anon2015Observ, title = {Observation of Treatment Patterns With Lucentis® (Ranibizumab) in Real-life Conditions in All Approved Indications}, author = {Anonymous}, journal = {Novartis Pharmaceuticals}, year = {2015}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings